{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260806779846/en/Rosen-Law-Firm-Urges-ARS-Pharmaceuticals-Inc.-NASDAQ-SPRY-Stockholders-with-Large-Losses-to-Contact-the-Firm-for-Information-About-Their-Rights", "message": "News view counter 868982 successfully enlarged"}